arcomedlab, startup from our 7^th Generation , just achieved one of its most notable breakthrough: its Drop Release System (DRS) is now being implemented in five medical centers across Chile, with plans to expand into other Latin American and European countries.

Ilan Rosenberg, CEO of arcomedlab, explains: “The DRS consists of a reservoir within the implant that stores 5 to 10 milliliters of a drug, typically antibiotics, based on the surgeon’s estimation. The medication is then released gradually by gravity.”

This innovation allows the targeted area to receive a controlled, localized dose of medication, tailored to meet the medical team’s specific objectives. “This is a unique development on a global scale,” says Rosenberg, “and it marks a turning point in modern medicine by transforming postoperative treatment, delivering medication drop by drop over a period of 7 to 10 days.”

Rosenberg is careful to note that in cranial implant surgeries, where infection risks can range from 5% to 10% due to the proximity to the brain, surgeons seek both systemic and localized antibiotic treatments. “We don’t determine which medications to release,” he adds. “We simply provide a new tool—an option that has already shown very promising results.”

Beyond anatomical reconstruction, arcomedlab aims to redefine implants by making them interactive through its DRS technology. “Our long-term vision is for every implant designed to reconstruct any part of the body to include this system,” says Rosenberg. “The DRS functions as a pump, capable of delivering any medication deemed necessary by the medical team, for as long as required—and can even be removed afterward.”

On the commercial front, arcomedlab is looking to establish Point of Care (POC) hubs in medical centers worldwide. “A few years ago, after being named Startup of the Year by a Chilean publication, we visited several medical centers in Switzerland. We discovered that none of them had technology comparable to ours, which sparked interest from Europe, Israel, and Saudi Arabia. We now hope to bring our innovations to these markets and continue expanding beyond Latin America,” Rosenberg concludes.

Recently, arcomedlab has made another important stride by opening a new laboratory at the prestigious Meds Clinic in Santiago. This marks the company’s first Print On Point (POP) facility, which focuses on 3D printing craniofacial, sternal, and hip implants, along with other bone structures and implants for ligament fixation and meniscus reconstruction, all crafted from synthetic materials.